Literature DB >> 24531223

Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter].

Peter W G Tennant1, Svetlana V Glinianaia, Rudy W Bilous, Judith Rankin, Ruth Bell.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24531223     DOI： 10.1007/s00125-014-3191-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study.

Authors:  R Bell; S V Glinianaia; P W G Tennant; R W Bilous; J Rankin
Journal:  Diabetologia       Date:  2012-02-08       Impact factor: 10.122

Review 2.  Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.

Authors:  A Walfisch; A Al-maawali; M E Moretti; C Nickel; G Koren
Journal:  J Obstet Gynaecol       Date:  2011-08       Impact factor: 1.246

3.  Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?

Authors:  Gareth Lewis; Alexander P Maxwell
Journal:  Diabetologia       Date:  2014-02-15       Impact factor: 10.122

4.  Major congenital malformations after first-trimester exposure to ACE inhibitors.

Authors:  William O Cooper; Sonia Hernandez-Diaz; Patrick G Arbogast; Judith A Dudley; Shannon Dyer; Patricia S Gideon; Kathi Hall; Wayne A Ray
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 5.  Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review.

Authors:  Marina Bullo; Sibylle Tschumi; Barbara S Bucher; Mario G Bianchetti; Giacomo D Simonetti
Journal:  Hypertension       Date:  2012-07-02       Impact factor: 10.190

6.  Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study.

Authors:  De-Kun Li; Chunmei Yang; Susan Andrade; Venessa Tavares; Jeannette R Ferber
Journal:  BMJ       Date:  2011-10-18

7.  Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study.

Authors:  Peter W G Tennant; Svetlana V Glinianaia; Rudy W Bilous; Judith Rankin; Ruth Bell
Journal:  Diabetologia       Date:  2013-11-29       Impact factor: 10.122
  7 in total
  1 in total

Review 1.  Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding.

Authors:  Lene Ringholm; Julie Agner Damm; Marianne Vestgaard; Peter Damm; Elisabeth R Mathiesen
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.